My bookmarksSign up free
Source

Council Decision (EU) 2015/1855 of 13 October 2015 establishing the position to be taken on behalf of the European Union within the Council for Trade-Related Aspects of Intellectual Property Rights and the General Council of the World Trade Organisation as regards the request from least-developed country Members for an extension of the transitional period under paragraph 1 of Article 66 of the Agreement on Trade-Related Aspects of Intellectual Property Rights concerning certain obligations related to pharmaceutical products, and for a waiver of the obligations under paragraphs 8 and 9 of Article 70 of that Agreement

Council Decision (EU) 2015/1855 of 13 October 2015 establishing the position to be taken on behalf of the European Union within the Council for Trade-Related Aspects of Intellectual Property Rights and the General Council of the World Trade Organisation as regards the request from least-developed country Members for an extension of the transitional period under paragraph 1 of Article 66 of the Agreement on Trade-Related Aspects of Intellectual Property Rights concerning certain obligations related to pharmaceutical products, and for a waiver of the obligations under paragraphs 8 and 9 of Article 70 of that Agreement

Decision (EU) 2015/1855 Β· Decision Β· 2 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

Open β†—

The position to be taken on behalf of the European Union within the Council for Trade-Related Aspects of Intellectual Property Rights and the General Council of the World Trade Organisation (β€˜WTO’), shall be the following: (a) to agree to: (i) the request from least-developed country (β€˜LDC’) Members for an extension of the transitional period under paragraph 1 of Article 66 of the Agreement on Trade-Related Aspects of Intellectual Property Rights (the β€˜TRIPS Agreement’) concerning certain obligations related to pharmaceutical products; and (ii) the request to waive the obligations of LDC Members under paragraphs 8 and 9 of Article 70 of the TRIPS Agreement; and (b) to agree either to: (i) the request for the extension referred to in point (a)(i) of this Article, or the waiver referred to in point (a)(ii) of this Article, or both, to apply for as long as each LDC Member remains an LDC; or (ii) the request for a temporary extension or a temporary waiver, or both, if that request is also acceptable to the other WTO Members.

Other acts of the same type
Decision (EU) 2020/440 of the European Central Bank of 24 March 2020 on a temporary pandemic emergency purchase programme (ECB/2020/17)Decision (EU) 2020/441 of the European Central Bank of 24 March 2020 amending Decision (EU) 2016/948 of the European Central Bank on the implementation of the corporate sector purchase programme (ECB/2020/18)Council Decision (CFSP) 2020/434 of 23 March 2020 amending Decision 2013/34/CFSP on a European Union military mission to contribute to the training of the Malian Armed Forces (EUTM Mali)Council Decision (CFSP) 2020/435 of 23 March 2020 amending Decision 2011/173/CFSP concerning restrictive measures in view of the situation in Bosnia and HerzegovinaCommission Decision (EU) 2020/1472 of 20 March 2020 on the State aid SA.39078 – 2019/C (ex 2014/N) which Denmark implemented for Femern A/S (notified under document C(2020) 1683) (Only the English text is authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2020/414 of 19 March 2020 amending Implementing Decision (EU) 2019/570 as regards medical stockpiling rescEU capacities (notified under document C(2020) 1827) (Text with EEA relevance)Council Implementing Decision (CFSP) 2020/417 of 19 March 2020 implementing Decision 2010/788/CFSP concerning restrictive measures against the Democratic Republic of the CongoCouncil Decision (CFSP) 2020/408 of 17 March 2020 amending Decision 2013/798/CFSP concerning restrictive measures against the Central African RepublicDecision (EU) 2020/407 of the European Central Bank of 16 March 2020 amending Decision (EU) 2019/1311 on a third series of targeted longer-term refinancing operations (ECB/2020/13)Council Decision (CFSP) 2020/399 of 13 March 2020 amending Decision 2014/145/CFSP concerning restrictive measures in respect of actions undermining or threatening the territorial integrity, sovereignty and independence of UkraineCommission Implementing Decision (EU) 2020/433 of 12 March 2020 concerning the extension of the action taken by the Swedish Chemicals Agency permitting the making available on the market and use of the biocidal product Care Plus Mosquito Net in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (notified under document C(2020) 1342) (Only the Swedish text is authentic)Commission Implementing Decision (EU) 2020/388 of 6 March 2020 laying down rules for the application of Council Directive 90/428/EEC as regards the derogations from the rules of equestrian competitions and amending Commission Decision 2009/712/EC as regards references to zootechnical legislation (notified under document C(2020) 1269) (Text with EEA relevance)

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next